JP2021503015A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021503015A5 JP2021503015A5 JP2020545238A JP2020545238A JP2021503015A5 JP 2021503015 A5 JP2021503015 A5 JP 2021503015A5 JP 2020545238 A JP2020545238 A JP 2020545238A JP 2020545238 A JP2020545238 A JP 2020545238A JP 2021503015 A5 JP2021503015 A5 JP 2021503015A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- pharmaceutical composition
- composition according
- modified
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024172933A JP7787265B2 (ja) | 2017-11-15 | 2024-10-02 | 非骨髄破壊的な骨髄再構成のための方法および組成物 |
| JP2025225428A JP2026050368A (ja) | 2017-11-15 | 2025-12-03 | 非骨髄破壊的な骨髄再構成のための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762586813P | 2017-11-15 | 2017-11-15 | |
| US62/586,813 | 2017-11-15 | ||
| PCT/US2018/061211 WO2019099619A1 (en) | 2017-11-15 | 2018-11-15 | Methods and compositions for non-myeloablative bone marrow reconstitution |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024172933A Division JP7787265B2 (ja) | 2017-11-15 | 2024-10-02 | 非骨髄破壊的な骨髄再構成のための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021503015A JP2021503015A (ja) | 2021-02-04 |
| JP2021503015A5 true JP2021503015A5 (https=) | 2021-12-23 |
| JP7568507B2 JP7568507B2 (ja) | 2024-10-16 |
Family
ID=66539907
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545238A Active JP7568507B2 (ja) | 2017-11-15 | 2018-11-15 | 非骨髄破壊的な骨髄再構成のための方法および組成物 |
| JP2024172933A Active JP7787265B2 (ja) | 2017-11-15 | 2024-10-02 | 非骨髄破壊的な骨髄再構成のための方法および組成物 |
| JP2025225428A Pending JP2026050368A (ja) | 2017-11-15 | 2025-12-03 | 非骨髄破壊的な骨髄再構成のための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024172933A Active JP7787265B2 (ja) | 2017-11-15 | 2024-10-02 | 非骨髄破壊的な骨髄再構成のための方法および組成物 |
| JP2025225428A Pending JP2026050368A (ja) | 2017-11-15 | 2025-12-03 | 非骨髄破壊的な骨髄再構成のための方法および組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12194062B2 (https=) |
| EP (2) | EP4674969A2 (https=) |
| JP (3) | JP7568507B2 (https=) |
| KR (1) | KR20200089289A (https=) |
| CN (1) | CN111417407A (https=) |
| AU (2) | AU2018367546B2 (https=) |
| BR (1) | BR112020009377A2 (https=) |
| CA (1) | CA3082404A1 (https=) |
| ES (1) | ES3039609T3 (https=) |
| IL (1) | IL274632B2 (https=) |
| MX (2) | MX2020004811A (https=) |
| SG (1) | SG11202004145QA (https=) |
| WO (1) | WO2019099619A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| WO2015105955A1 (en) | 2014-01-08 | 2015-07-16 | Flodesign Sonics, Inc. | Acoustophoresis device with dual acoustophoretic chamber |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| WO2021155351A1 (en) * | 2020-01-31 | 2021-08-05 | Gumrukcu Serhat | Compositions and methods for providing chemoprotective effects |
| US12390491B2 (en) * | 2020-01-31 | 2025-08-19 | Gtech Bio Llc | Compositions and methods for providing chemoprotective effects |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL109168A0 (en) | 1993-04-01 | 1994-06-24 | Univ Columbia | A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs |
| JP5179697B2 (ja) | 2001-07-10 | 2013-04-10 | ジョンソン・アンド・ジョンソン・リサーチ・プロプライエタリー・リミテッド | 造血前駆細胞を遺伝的に改変する方法及び改変された細胞の使用 |
| US7737124B2 (en) * | 2001-09-13 | 2010-06-15 | California Institute Of Technology | Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell |
| US20030099621A1 (en) * | 2001-11-29 | 2003-05-29 | Robert Chow | Stem cell screening and transplantation therapy for HIV infection |
| JP2010509360A (ja) * | 2006-11-08 | 2010-03-25 | アルダジェン， インコーポレイテッド | 幹細胞移植を補助するためにＡＬＤＨｂｒ細胞を使用する方法 |
| WO2009094456A2 (en) * | 2008-01-22 | 2009-07-30 | Johns Hopkins University | Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection |
| ES2657737T3 (es) | 2009-07-15 | 2018-03-06 | Calimmune Inc. | Vector dual para la inhibición del virus de la inmunodeficiencia humana |
| US8837250B2 (en) | 2010-07-20 | 2014-09-16 | Taiwan Semiconductor Manufacturing Co., Ltd. | Method and apparatus for word line decoder layout |
| JP2015504047A (ja) * | 2011-12-22 | 2015-02-05 | イェダ リサーチ アンド デベロップメント カンパニー リミテッド | 安定かつ長期の生着のための併用療法 |
| AU2013204327B2 (en) * | 2012-04-20 | 2016-09-01 | Aviagen | Cell transfection method |
| EP4286517A3 (en) * | 2013-04-04 | 2024-03-13 | President and Fellows of Harvard College | Therapeutic uses of genome editing with crispr/cas systems |
-
2018
- 2018-11-15 IL IL274632A patent/IL274632B2/en unknown
- 2018-11-15 ES ES18879410T patent/ES3039609T3/es active Active
- 2018-11-15 MX MX2020004811A patent/MX2020004811A/es unknown
- 2018-11-15 BR BR112020009377-7A patent/BR112020009377A2/pt unknown
- 2018-11-15 CA CA3082404A patent/CA3082404A1/en active Pending
- 2018-11-15 EP EP25191496.6A patent/EP4674969A2/en active Pending
- 2018-11-15 SG SG11202004145QA patent/SG11202004145QA/en unknown
- 2018-11-15 US US16/191,816 patent/US12194062B2/en active Active
- 2018-11-15 CN CN201880077273.2A patent/CN111417407A/zh active Pending
- 2018-11-15 EP EP18879410.1A patent/EP3710013B1/en active Active
- 2018-11-15 WO PCT/US2018/061211 patent/WO2019099619A1/en not_active Ceased
- 2018-11-15 AU AU2018367546A patent/AU2018367546B2/en active Active
- 2018-11-15 KR KR1020207016902A patent/KR20200089289A/ko not_active Ceased
- 2018-11-15 JP JP2020545238A patent/JP7568507B2/ja active Active
-
2020
- 2020-07-13 MX MX2025004115A patent/MX2025004115A/es unknown
-
2024
- 2024-08-29 AU AU2024216450A patent/AU2024216450A1/en active Pending
- 2024-10-02 JP JP2024172933A patent/JP7787265B2/ja active Active
- 2024-12-13 US US18/980,429 patent/US20250228898A1/en active Pending
-
2025
- 2025-12-03 JP JP2025225428A patent/JP2026050368A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021503015A5 (https=) | ||
| ES2992295T3 (es) | Composiciones potenciadoras de Vcn y métodos de uso de las mismas | |
| US20250019433A1 (en) | Methods and compositions for modulating car-t activity | |
| EP3471743B1 (en) | Strategies to assess and/or produce cell populations with predictive engraftment potential | |
| JP2020505934A5 (https=) | ||
| IL274632B2 (en) | Methods and compositions for non-myeloablative bone marrow reconstitution | |
| EP3519561A1 (en) | Modified stem cell memory t cells, methods of making and methods of using same | |
| EP4090743A1 (en) | Modification of blood type antigens | |
| US20240060090A1 (en) | Genetically modified induced pluripotent stem cells and methods of use thereof | |
| JP7633155B2 (ja) | 人工トランス活性化因子による選択 | |
| Larochelle et al. | In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene | |
| JP2021522837A (ja) | 造血幹細胞移植のための組成物及び方法 | |
| US20240181005A1 (en) | Compositions, systems, and methods for generating gene-edited cells | |
| JPWO2018088519A1 (ja) | 遺伝子導入細胞の製造方法 | |
| CN112601812A (zh) | 基因疗法 | |
| WO2019185920A1 (en) | Tale-nucleases for allele-specific codon modification | |
| WO2020158924A1 (ja) | 母児間免疫寛容を誘導する方法 | |
| JP2020517289A5 (https=) | ||
| KR20250084928A (ko) | 유전자 전달 효율이 향상된 트랜스포사제 돌연변이 | |
| CN121079404A (zh) | 用于基因组编辑的组合物和方法 | |
| JP2023523334A (ja) | ｉｎ ｖｉｖｏで造血幹細胞及び造血前駆細胞を形質導入するための方法及び組成物 | |
| JP2023512287A5 (https=) | ||
| US20250177447A1 (en) | Gprc5d-specific antibody constructs and compositions thereof | |
| Quinn et al. | 122. Genetic Modification of Target Cells by Direct Delivery of Active Protein | |
| Qiu et al. | Cell Insight |